Walleye Capital LLC Ani Pharmaceuticals Inc Call Options Transaction History

Walleye Capital LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2020 May 15, 2020	SELL	$30.35 - $67.14 $103,190 - $228,276	-3,400 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$55.65 - $79.83 $133,560 - $191,592	-2,400 Reduced 41.38%	3,400 $210,000
Q3 2019 Nov 14, 2019	SELL	$64.7 - $85.39 $964,030 - $1.27 Million	-14,900 Reduced 71.98%	5,800 $423,000
Q2 2019 Aug 14, 2019	SELL	$67.77 - $82.2 $955,557 - $1.16 Million	-14,100 Reduced 40.52%	20,700 $1.7 Million
Q1 2019 May 15, 2019	BUY	$45.83 - $70.54 $1.59 Million - $2.45 Million	34,800 New	34,800 $2.46 Million

212

18.8M

11.7K

10.5K

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $939M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.